Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920929 · ClinicalTrials.gov registry record · NA
PICC Asymptomatic Thrombosis Study: A Pilot Study
A NA study, sponsored by Access Vascular.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04920929 is a NA study that was terminated before completion, run by Access Vascular. The registered enrollment target is 7 participants.
The verdict
NCT04920929, a NA study, was terminated before completion, sponsored by Access Vascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The study purpose is to perform a preliminary, comparative evaluation of the Hydrophilic Biomaterial technology to confirm the performance of the catheter, by using UltraSound technology in-vivo.
Interventions
- DEVICE Hydrophilic Biomaterial
- DEVICE Thermoplastic Polyurethane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2021-10-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04920929
The ClinicalTrials.gov registry entry for NCT04920929 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Access Vascular, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrophilic Biomaterial is the first listed.
NCT04920929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04920929 about?
NCT04920929 is a clinical study titled "PICC Asymptomatic Thrombosis Study: A Pilot Study". The study purpose is to perform a preliminary, comparative evaluation of the Hydrophilic Biomaterial technology to confirm the performance of the catheter, by using UltraSound technology in-vivo.
What is the current status of trial NCT04920929?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2021-07-15. Estimated completion is 2021-10-07.
What interventions are being tested in trial NCT04920929?
The interventions under investigation include: Hydrophilic Biomaterial (DEVICE), Thermoplastic Polyurethane (DEVICE).
Who is sponsoring clinical trial NCT04920929?
This trial is sponsored by Access Vascular, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.